What Causes Heart Palpitations Explained Comprehensively

Published

Table of Contents

Heart palpitations—those sudden, often alarming sensations of a racing, fluttering, or irregular heartbeat—can stem from a complex interplay of physiological, lifestyle, and structural factors. While occasional palpitations may be harmless, understanding their underlying mechanisms is critical for distinguishing benign triggers from serious cardiac or neurological conditions. From the biochemical surge of adrenaline during stress to the arrhythmogenic effects of stimulants or electrolyte imbalances, the causes span a spectrum that demands precise medical evaluation. This analysis explores the multifaceted origins of palpitations, integrating clinical pathways, diagnostic insights, and evidence-based interventions to clarify when to seek immediate care versus adopt preventive strategies.

The human heart’s rhythm is a delicate balance of electrical impulses and mechanical function, easily disrupted by internal and external stressors. Medical conditions such as hyperthyroidism or anemia alter metabolic demands, while lifestyle choices—from excessive caffeine intake to chronic sleep deprivation—can destabilize autonomic regulation. Structural abnormalities, such as hypertrophic cardiomyopathy or mitral valve prolapse, further complicate the diagnostic landscape, often requiring advanced imaging and electrophysiological studies. Neurological influences, including panic attacks or migraines, introduce additional layers of complexity, where autonomic dysregulation triggers cardiac symptoms without primary cardiac pathology. By dissecting these pathways, this discussion equips readers with a structured framework to interpret symptoms and advocate for appropriate medical assessment.

what causes heart palpitations

Medical and Physiological Triggers of Heart Palpitations

Heart palpitations, characterized by an irregular, rapid, or forceful heartbeat, often stem from disruptions in the autonomic nervous system, hormonal fluctuations, or underlying medical conditions. The sympathetic nervous system (SNS) and hypothalamic-pituitary-adrenal (HPA) axis play central roles in modulating cardiac function through neurochemical pathways. Adrenaline (epinephrine) and cortisol, released during stress or physiological demands, bind to beta-1 adrenergic receptors on cardiac myocytes, increasing cyclic AMP (cAMP) production. This cascade enhances sodium and calcium influx, accelerating sinoatrial (SA) node depolarization and atrial conduction velocity, resulting in tachycardia. Chronic activation of these pathways may also lead to ventricular remodeling, predisposing individuals to arrhythmias.

The interplay between hormonal regulation and cardiac electrophysiology underscores why stress, anxiety, and metabolic imbalances frequently trigger palpitations. Below, structured analyses explore key physiological mechanisms, including hormonal imbalances, electrolyte disturbances, and external stimulants, alongside their clinical manifestations.

Role of Adrenaline and Stress Hormones in Tachycardia

The fight-or-flight response mediated by the SNS and adrenal medulla releases adrenaline and noradrenaline, which directly influence cardiac rhythm. Adrenaline binds to beta-1 adrenergic receptors on the SA node, increasing funny current (If) and L-type calcium channel activity, thereby shortening the SA node action potential duration and elevating the heart rate (HR). Concurrently, cortisol, secreted by the adrenal cortex via the HPA axis, enhances gluconeogenesis and lipolysis, indirectly supporting sustained sympathetic drive. Prolonged cortisol exposure may also downregulate muscarinic receptors, reducing parasympathetic (vagal) tone and further promoting tachycardia.

Biochemical Pathway Summary:

Adrenaline → β₁-AR activation → ↑cAMP → ↑Ca²⁺ influx → ↑SA node firing rate → Tachycardia
Cortisol (chronic) → ↓M₂ muscarinic receptor density → ↓Vagal tone → Baseline HR elevation
In clinical scenarios, acute stress (e.g., public speaking, trauma) triggers transient palpitations via this mechanism, while chronic stress (e.g., burnout, PTSD) may lead to persistent tachycardia or atrial fibrillation (AF) due to structural cardiac changes.

Comparison of Medical Conditions Triggering Palpitations

Underlying medical conditions disrupt cardiac electrophysiology through distinct pathways. Below is a structured comparison of hyperthyroidism, anemia, and electrolyte imbalances, highlighting their mechanisms, symptoms, and common clinical presentations.
Trigger Physiological Mechanism Symptoms Common Scenarios
Hyperthyroidism Excess thyroid hormones (T₃/T₄) increase β-adrenergic receptor sensitivity, mimicking sympathetic overactivity. Elevated thyroid-stimulating hormone (TSH) suppression and iodine metabolism disorders (e.g., Graves’ disease) accelerate SA node automaticity and AV node conduction, reducing refractory periods.
  • Palpitations (often paroxysmal atrial fibrillation)
  • Heat intolerance, tremors, weight loss
  • Diaphoresis, anxiety, fatigue
  • Autoimmune thyroiditis (Graves’ disease)
  • Thyroid nodules or toxic multinodular goiter
  • Postpartum thyroiditis
Anemia Reduced hemoglobin concentration decreases oxygen-carrying capacity, prompting compensatory mechanisms: ↑cardiac output (CO) via ↑HR (via baroreceptor reflex) and ↑stroke volume (SV). Chronic anemia may lead to ventricular hypertrophy due to sustained volume overload.
  • Palpitations (especially with exertion)
  • Dyspnea, fatigue, pallor
  • Tinnitus, headache (in severe cases)
  • Iron-deficiency anemia (most common)
  • Vitamin B12/folate deficiency (megaloblastic anemia)
  • Hemolytic anemia (e.g., sickle cell disease)
Electrolyte Imbalances Hypokalemia (↓K⁺): Alters resting membrane potential, increasing ectopic foci and afterdepolarizations, predisposing to ventricular arrhythmias (e.g., torsades de pointes).

Hypomagnesemia (↓Mg²⁺): Impairs Na⁺/K⁺-ATPase function, prolonging action potential duration (APD) and QT interval.

Hypercalcemia (↑Ca²⁺): Enhances L-type calcium channel activity, increasing SA node automaticity and AV conduction velocity.
  • Palpitations (often irregular or skipped beats)
  • Muscle cramps, weakness (hypokalemia/hypomagnesemia)
  • Nausea, polyuria (hypercalcemia)
  • Diuretic use (e.g., furosemide)
  • Chronic alcoholism (magnesium deficiency)
  • Primary hyperparathyroidism (hypercalcemia)
Key Insight:
Electrolyte imbalances often coexist with acid-base disorders (e.g., metabolic alkalosis in vomiting-induced hypokalemia), exacerbating cardiac instability. Monitoring serum K⁺, Mg²⁺, and Ca²⁺ is critical in patients with recurrent palpitations.

Effects of Caffeine and Nicotine on Cardiac Rhythm

Caffeine and nicotine disrupt cardiac electrophysiology through adenosine receptor antagonism and nicotinic acetylcholine receptor (nAChR) stimulation, respectively. Their mechanisms differ but converge on SA node overdrive and conduction abnormalities.

Caffeine:

  • Adenosine Receptor Blockade: Adenosine normally slows HR via A₁ receptor-mediated K⁺ efflux in the SA node. Caffeine inhibits this effect, leading to ↑HR and ↑AV conduction velocity.
  • Phosphodiesterase Inhibition: Elevates cAMP, enhancing calcium influx and myocardial contractility, which may trigger premature atrial contractions (PACs) or atrial fibrillation (AF).
  • Dose-Dependent Effects:
    • <200 mg caffeine (≈2 cups coffee): Mild tachycardia, ↑HR by 5–10 bpm.

    >400 mg (≈4 cups): Risk of paroxysmal supraventricular tachycardia (PSVT) or ventricular ectopy. Nicotine:

  • nAChR Stimulation: Nicotine binds to ganglionic nAChRs, releasing acetylcholine (ACh) and noradrenaline, which ↑HR via β₁-AR activation and ↑SA node firing rate.
  • Autonomic Dysregulation: Chronic use leads to downregulation of muscarinic receptors, reducing vagal tone and ↑baseline HR.
  • Vascular Effects: Vasoconstriction increases afterload, forcing the heart to work harder and potentially triggering palpitations during withdrawal (due to ↑ACh release from denervated receptors).

    • Clinical Correlation:

  • Caffeine-induced palpitations are dose-dependent and often

    • what causes heart palpitations - Ilustrasi 2

    Lifestyle and Behavioral Factors in Heart Palpitations

    Lifestyle and behavioral choices significantly influence cardiac autonomic regulation, often precipitating palpitations through disruptions in neural, hormonal, and metabolic pathways. Sleep deprivation, excessive caffeine or stimulant use, high-intensity exercise, and chronic stress alter sympathetic-parasympathetic balance, leading to arrhythmias or perceived palpitations. This section examines the physiological cascades linking behavioral triggers to cardiac dysrhythmias, emphasizing mechanistic pathways and quantifiable thresholds where risk escalates.

    Sleep Deprivation and Autonomic Imbalance Leading to Palpitations

    Sleep loss initiates a cascade of neuroendocrine and autonomic adaptations that destabilize heart rate variability (HRV) and predispose individuals to palpitations. The following flowchart outlines the sequential physiological disruptions:
    Sleep Deprivation → Cortisol Spike → Sympathetic Dominance → Reduced HRV → Palpitations
    1. Sleep Loss (≤6 hours/night)
  • Chronic sleep restriction (<7 hours) suppresses melatonin and disrupts circadian rhythmicity, while acute deprivation (<4 hours) triggers compensatory arousal mechanisms.
  • Key Pathway: Reduced slow-wave sleep (NREM Stage 3) impairs baroreflex sensitivity, a critical mediator of HRV.

    • 2. Cortisol Surge (HPA Axis Activation)

  • Sleep deprivation elevates cortisol by 30–50% within 24 hours, peaking at 06:00–08:00 despite misaligned circadian cues.
  • Mechanism: Cortisol enhances β-adrenergic receptor sensitivity, amplifying catecholamine effects on the sinoatrial node.

    • 3. Sympathetic Dominance

  • Elevated norepinephrine (NE) levels (up to 200% increase post-sleep deprivation) shift autonomic tone toward sympathetic overactivity.
  • Cardiac Impact: NE binds to SA node β₁-receptors, increasing automaticity and reducing atrial refractory periods, fostering premature atrial contractions (PACs).

    • 4. Heart Rate Variability (HRV) Decline

  • HRV, a marker of parasympathetic (vagal) tone, decreases by 20–40% after sleep loss, correlating with palpitations in susceptible individuals.
  • Clinical Link: Low HRV (<15 ms SDNN) is associated with a 3-fold higher risk of atrial fibrillation (AF) in sleep-deprived populations (Study: Journal of Clinical Sleep Medicine, 2018).

    • High-Intensity Exercise and Post-Workout Cardiac Responses

    High-intensity interval training (HIIT) and anaerobic exercises (e.g., sprinting) acutely elevate heart rate (HR) and oxygen demand, often triggering palpitations secondary to metabolic stress. The immediate post-workout period is particularly critical due to oxygen debt and lactic acid accumulation, which may persist for 30–60 minutes.
    Post-Exercise Palpitations: Mechanisms
    Oxygen debt → Lactic acidosis → Sympathetic overdrive → Atrial/ventricular ectopy
    High-Intensity Exercise Modalities and Their Effects
    1. High-Intensity Interval Training (HIIT)
    2. Example: 30-second sprints at 90% VO₂ max with 1-minute recovery (Tabata protocol).
    3. Immediate Post-Workout Response:
    4. HR peaks at 180–200 bpm (220-age formula), with recovery lagging by 5–10 bpm/minute.
    5. Lactic acid accumulation (up to 20 mM) lowers extracellular pH, sensitizing cardiac myocytes to catecholamines.
    6. Palpitation Trigger: PACs or PVCs in 10–15% of athletes post-HIIT (observed in European Journal of Sport Science, 2020).
    7. Sprint Interval Training (SIT)
    8. Example: 4 × 400m sprints at 105% VO₂ max with 4-minute recovery.
    9. Post-Exercise Effects:
    10. Oxygen debt repayment elevates HR by 10–15% above resting levels for 30 minutes.
    11. Mechanism: Increased venous return and reduced stroke volume variability may induce atrial stretch, triggering PACs.
    12. Heavy Resistance Training (e.g., Weightlifting)
    13. Example: 5 sets of 5 reps at 85% 1RM (e.g., deadlifts).
    14. Cardiac Response:
    15. Valsalva maneuver (forced exhalation) during lifts increases intrathoracic pressure, reducing venous return and causing transient bradycardia followed by tachycardia.
    16. Palpitation Risk: 5–8% incidence of PVCs post-session (linked to Journal of Strength and Conditioning Research, 2019).

    Alcohol Consumption and Atrial Fibrillation Risk

    Alcohol disrupts cardiac electrophysiology through direct toxic effects on myocytes, autonomic dysregulation, and electrolyte imbalances. Moderate intake (≤1 drink/day) may elevate AF risk by 17%, while binge drinking (≥5 drinks/session) increases risk by 41% (per BMJ, 2017). The mechanisms differ by consumption pattern and dose.
    Alcohol-Induced AF Pathways
    Acute: Ethanol → ATP-sensitive K⁺ channel inhibition → Delayed afterdepolarizations (DADs) → Triggered activity Chronic: Holmium toxicity → Fibrosis → Reentry circuits
    Comparative Impact of Moderate vs. Binge Drinking on Heart Rhythm
    1. Moderate Consumption (≤14g ethanol/day)
    2. Electrolyte Disturbances: Mild hypokalemia (serum K⁺ drops by 0.2–0.5 mEq/L) due to increased renal excretion.
    3. Autonomic Shift: Parasympathetic withdrawal (reduced HRV by 10–15%) without significant arrhythmias in healthy individuals.
    4. AF Risk: 17% higher than abstainers (Circulation, 2018).
    5. Binge Drinking (≥60g ethanol/session)
    6. Acute Toxicity: Ethanol metabolites (acetaldehyde) inhibit L-type Ca²⁺ channels, prolonging atrial refractoriness.
    7. Electrolyte Crisis: Severe hypomagnesemia (Mg²⁺ <1.5 mg/dL) and hypokalemia (K⁺ <3.5 mEq/L) within 6–12 hours.
    8. AF Risk: 41% higher; binge episodes trigger 30% of "holiday heart" AF cases (European Heart Journal, 2015).

    Chronic Stress and Anxiety-Induced Palpitations

    Chronic stress and anxiety sustain palpitations through a triad of neuroendocrine, autonomic, and musculoskeletal mechanisms. The amygdala, hypothalamic-pituitary-adrenal (HPA) axis, and peripheral muscle tension create a feedback loop that perpetuates sympathetic overactivity.
    Stress-Anxiety Palpitation Cascade
    Amydala activation → HPA axis cortisol release → Sympathetic dominance → Muscle tension → Baroreflex resetting → Palpitations
    Key Pathophysiological Contributors
    1. Amygdala Hyperactivity
    2. Chronic stress amplifies amygdala-mediated threat responses, increasing NE release by 50–100%.
    3. Cardiac Link: NE binds to ventricular β₁-receptors, prolonging QT interval and predisposing to torsades de pointes in susceptible individuals.
    4. HPA Axis Dysregulation
    5. Persistent cortisol elevation (diurnal rhythm disruption) downregulates glucocorticoid receptors, reducing negative feedback on the HPA axis.
    6. Result: Sustained sympathetic tone (HRV <10 ms SDNN) correlates with a 2.5× higher palpitation frequency (Psychosomatic Medicine, 2016).
    7. Muscle Tension and Baroreflex Resetting
    8. Chronic tension (e.g., jaw clenching, shoulder stiffness) activates muscle spindles, signaling the brainstem to increase sympathetic outflow.
    9. Mechanism: Elevated peripheral resistance resets baroreceptors, triggering compensatory tachycardia (10–20 bpm above baseline).

    Stimulant-Induced Palpitations: Mechanisms and Dosage Thresholds

    Stimulants disrupt cardiac electrophysiology through adrenergic overactivation, ion channel blockade, and proarr

    Cardiac and Structural Abnormalities Underlying Heart Palpitations

    Structural and cardiac abnormalities represent a critical subset of causes for heart palpitations, often linked to underlying pathologies that disrupt electrical conduction, mechanical function, or both. These conditions range from congenital defects to acquired diseases, each requiring a systematic diagnostic approach to distinguish benign from life-threatening arrhythmias. The interplay between anatomical changes—such as hypertrophic myocardium or valvular dysfunction—and electrophysiological disturbances (e.g., re-entry circuits) underscores the necessity for multimodal imaging, genetic testing, and electrocardiographic analysis. Below, a structured workflow for diagnosis, mechanistic explanations of arrhythmogenic processes, and comparative analysis of arrhythmic syndromes are provided to elucidate their clinical significance.

    Diagnostic Workflow for Structural Heart Conditions Causing Palpitations

    The evaluation of structural heart diseases as a cause of palpitations follows a tiered approach, integrating patient history, physical examination, and advanced imaging to identify specific pathologies. Hypertrophic cardiomyopathy (HCM) and mitral valve prolapse (MVP) are common structural causes, while coronary artery disease (CAD) and congenital anomalies (e.g., long QT syndrome) require distinct diagnostic pathways. The workflow prioritizes non-invasive techniques before progressing to invasive studies, balancing sensitivity with patient safety.

    Key diagnostic steps:

  • Initial assessment:
  • History and symptoms: Family history of sudden cardiac death, exertional syncope, or prior arrhythmias; palpitations triggered by stress, caffeine, or sleep.
  • Physical examination: Murmurs (e.g., systolic ejection murmur in HCM, mid-systolic click in MVP), peripheral edema (suggesting heart failure), or irregular pulses (indicating arrhythmias).

    • - Electrocardiography (ECG):

  • Resting ECG: Identifies abnormal repolarization (e.g., prolonged QT in long QT syndrome), chamber hypertrophy (e.g., LVH in HCM), or conduction delays (e.g., bundle branch blocks in structural heart disease).
  • Holter/Event monitoring: Captures intermittent palpitations (e.g., paroxysmal atrial fibrillation) not detected on a standard ECG.

    • - Echocardiography (ECHO):

  • Transthoracic (TTE) or transesophageal (TEE): Assesses wall motion abnormalities, valvular dysfunction (e.g., MVP with prolapse >2mm), diastolic dysfunction (HCM), or pericardial disease.
  • Limitations: Poor acoustic windows (e.g., obesity, lung disease) may reduce diagnostic yield; stress echocardiography (dobutamine) can unmask latent ischemia or HCM.

    • - Cardiac Magnetic Resonance (MRI):

  • Indications: Suspected infiltrative cardiomyopathies (e.g., amyloidosis), fibrosis (late gadolinium enhancement), or congenital anomalies (e.g., anomalous coronary arteries).
  • Limitations: Contraindications (e.g., pacemakers, severe renal impairment), longer scan times, and higher costs compared to ECHO.

    • - Advanced imaging:

  • Coronary angiography/CT angiography: Evaluates CAD as a cause of palpitations via ischemia (e.g., angina-induced arrhythmias).
  • Electroanatomical mapping (EAM): Used in refractory cases (e.g., ventricular tachycardia in structural heart disease) to localize arrhythmogenic substrates.

    • Genetic testing:

  • Indicated for familial cardiomyopathies (e.g., HCM with MYH7, MYBPC3 mutations) or channelopathies (e.g., long QT syndrome with KCNQ1, SCN5A variants). Pre-symptomatic screening is critical for high-risk families.

    • Atrial Fibrillation: Mechanisms of Rhythm Disruption

    Atrial fibrillation (AF) is the most common sustained arrhythmia causing palpitations, characterized by disorganized atrial electrical activity with rapid, irregular ventricular responses. Three primary mechanisms contribute to its pathogenesis: re-entry circuits, ectopic foci, and pulmonary vein triggers.

    Re-entry circuits:

  • Macro-re-entry: Large-scale circuits involving the atrial myocardium, often facilitated by anatomical obstacles (e.g., scar tissue, valvular disease).
  • Micro-re-entry: Faster, smaller circuits within the atrial muscle, sustaining rapid, disorganized depolarizations.
  • Mechanism: A critical mass of fractionated electrograms (multiple deflections on ECG) reflects chaotic electrical wavelets, preventing effective atrial contraction.

    • Ectopic foci:

  • Focal triggers: Most commonly originate from the pulmonary veins (PVs), where autonomic nerve fibers and structural remodeling (e.g., fibrosis) create an arrhythmogenic substrate.
  • Triggered activity: Delayed afterdepolarizations (DADs) or early afterdepolarizations (EADs) in atrial myocytes can initiate premature beats, propagating into AF.
  • Clinical relevance: Pulmonary vein isolation (PVI) via catheter ablation targets these triggers, achieving sinus rhythm restoration in ~70% of paroxysmal AF cases.

    • Role of the pulmonary veins:

  • Anatomical basis: PVs lack a well-defined muscular sleeve, making them prone to focal discharges due to:
  • Autonomic modulation: Vagal stimulation (e.g., during sleep) increases PV ectopy.
  • Structural remodeling: Chronic AF begets AF via atrial fibrosis, creating a substrate for sustained re-entry.
  • ECG manifestations:
  • Irregularly irregular rhythm with absent P-waves.
  • Ventricular response: Often rapid (>100 bpm) unless controlled by AV nodal blockade (e.g., beta-blockers).

    • Coronary Artery Disease and Palpitations via Myocardial Ischemia

    Palpitations in coronary artery disease (CAD) arise from myocardial ischemia, where an imbalance between oxygen demand and supply triggers arrhythmias. The mechanism involves automaticity, re-entry, and triggered activity in ischemic zones, exacerbated by sympathetic overdrive and electrolyte shifts (e.g., potassium efflux).

    Pathophysiology of ischemia-induced palpitations:

  • Oxygen demand/supply mismatch:
  • Increased demand: Exertion, stress, or tachycardia elevates myocardial O₂ consumption.
  • Reduced supply: Fixed stenosis (>70%) or dynamic obstruction (e.g., vasospasm) limits coronary perfusion.
  • Result: Hypoxia activates ATP-sensitive potassium channels (KATP), leading to depolarization instability.

    • Electrophysiological consequences:

  • Automaticity: Ischemic Purkinje fibers or ventricular myocytes generate escape rhythms (e.g., accelerated idioventricular rhythm).
  • Re-entry: Conduction slowing (due to ischemia) and heterogeneous refractoriness create circuits for ventricular tachycardia (VT) or atrial arrhythmias.
  • Triggered activity: Early afterdepolarizations (EADs) in repolarized cells (e.g., during long QT) can precipitate torsades de pointes.

    • Clinical presentation and ECG patterns:

  • Angina-induced palpitations: Occur during stable angina (predictable with exertion) or variant angina (rest-related, due to vasospasm).
  • ECG findings:
  • ST-segment depression/elevation (subendocardial/transmural ischemia).
  • Premature ventricular contractions (PVCs) or non-sustained VT during episodes.
  • Bradycardia-tachycardia syndrome (e.g., sinus bradycardia with paroxysmal AF post-ischemia).

    • Diagram of myocardial oxygen demand/supply mismatch:

    Oxygen Demand (Y-axis) ↑
    ↑ ↑
    | |
    | |
    |______ Ischemia Zone |______ Normal Perfusion
    | |
    | |
    |______ Supply (X-axis) ↓

    - Critical threshold: When demand exceeds supply (e.g., during exertion), ischemic cascade activates:
    1. Metabolic acidosis (lactic acid accumulation).
    2. Electrolyte shifts (↑ extracellular K⁺, ↓ intracellular Ca²⁺).
    3. Autonomic imbalance (↑ sympathetic, ↓ parasympathetic tone).

    Long QT Syndrome and Palpitations: Genetic and Electrophysiological Basis

    Long QT syndrome (LQTS) is a channelopathy characterized by prolonged repolarization, predisposing to torsades de pointes (TdP) and sudden cardiac death. Palpitations in LQTS stem from abnormal ion channel function, primarily affecting potassium (IKs, IKr) and sodium (INa) currents, leading to EADs during the plateau phase of the action potential.

    Genetic mutations and repolarization defects:

  • Type 1 (LQT1): KCNQ1 mutation → ↓ IKs (slow

    • what causes heart palpitations - Ilustrasi 3

    Neurological and Psychological Influences on Heart Palpitations

    Heart palpitations often arise from complex interactions between the central nervous system, autonomic dysregulation, and psychological stressors. While cardiac factors dominate clinical suspicion, neurological and psychological triggers—including panic attacks, migraines, PTSD, and depression—contribute significantly to palpitatory symptoms through distinct pathophysiological mechanisms. These pathways frequently involve altered respiratory physiology, autonomic storm phenomena, or neurochemical imbalances that disrupt cardiac rhythm perception or directly modulate heart rate. Understanding these mechanisms is critical for accurate diagnosis, as misattribution to cardiac pathology may lead to unnecessary interventions.

    The interplay between the brain and heart is mediated by the autonomic nervous system, where sympathetic overactivation or parasympathetic withdrawal can manifest as palpitations. Psychological distress, particularly in conditions like anxiety disorders or depression, often exacerbates these symptoms through neurochemical cascades (e.g., noradrenaline surges) or structural abnormalities (e.g., brainstem lesions). Below, the key neurological and psychological pathways are dissected, including their physiological triggers and clinical management strategies.

    Panic Attacks and Hyperventilation Syndrome

    Panic attacks and hyperventilation syndrome (HVS) are primary psychological triggers of palpitations, driven by respiratory alkalosis and subsequent autonomic feedback loops. During a panic attack, rapid or shallow breathing reduces arterial CO₂ levels, leading to respiratory alkalosis, which induces vasodilation in cerebral and peripheral vessels. This vasodilation activates baroreceptors in the carotid sinus and aortic arch, triggering a reflexive bradycardia followed by compensatory sympathetic overactivation, manifesting as palpitations, chest tightness, and tremors.

    The pathway can be summarized as follows:

    Low CO₂ → Cerebral/Peripheral Vasodilation → Baroreceptor Activation (Carotid/Aortic) → Reflex Bradycardia → Sympathetic Compensation → Palpitations
    Hyperventilation syndrome exacerbates this cycle by sustaining alkalosis, further sensitizing the medullary chemoreceptors to CO₂ fluctuations. Patients often describe palpitations as "racing" or "skipping," accompanied by paresthesias (tingling) and lightheadedness. Management focuses on breathing retraining (e.g., diaphragmatic breathing, rebreathing techniques) and cognitive behavioral therapy (CBT) to disrupt the panic-spiral feedback loop.

    Migraines and Autonomic Storms via Trigeminal Activation

    Migraines, particularly those with aura, can provoke autonomic storms that trigger palpitations through trigeminal nerve-mediated sympathetic activation. The trigeminal autonomic reflex (TAR) links trigeminal nerve stimulation (e.g., during aura phase) to parasympathetic and sympathetic dysregulation. During a migraine aura, cortical spreading depression (CSD) activates meningeal nociceptors, which project to the trigeminal ganglion and subsequently engage the rostral ventrolateral medulla (RVLM)—a key sympathetic control center.

    This activation leads to:
    1. Increased cardiac sympathetic outflow (via RVLM → spinal cord → stellate ganglion).
    2. Parasympathetic withdrawal, reducing vagal tone.
    3. Release of neuropeptides (e.g., CGRP, substance P), which may sensitize cardiac receptors.

    The result is a paroxysmal sympathetic surge, manifesting as palpitations, tachycardia, or even atrial arrhythmias. Studies indicate that ~30% of migraine patients report palpitations during attacks, with aura phases showing higher prevalence. Management includes:

  • Triptans (e.g., sumatriptan) to inhibit TAR.
  • Beta-blockers (e.g., propranolol) to dampen sympathetic overactivity.
  • Calcitonin gene-related peptide (CGRP) antagonists for prophylaxis.

    • Neurological Conditions and Palpitations: Pathways and Management

    Neurological disorders disrupt autonomic regulation, often presenting with palpitations as a primary symptom. Below is a comparative table outlining key conditions, their neurological pathways, heart symptom triggers, and management strategies.
    Condition Neurological Pathway Heart Symptom Trigger Management Strategies
    Epilepsy (Temporal Lobe)
    • Hippocampal/amygdala seizures → Hypothalamic-pituitary-adrenal (HPA) axis activation.
    • Limbic system discharge → Sympathetic storm via RVLM.
    • Post-ictal parasympathetic rebound → Bradycardia followed by tachycardia.
    		 Palpitations during ictal phase (racing) or post-ictal (bradycardia → compensatory tachycardia).
    • Antiepileptics (e.g., levetiracetam, lacosamide).
    • Beta-blockers for symptomatic control.
    • Avoidance of pro-arrhythmic drugs (e.g., carbamazepine).
    Autonomic Neuropathy (Diabetic)
    • Dorsal root ganglion damage → Loss of cardiac afferent feedback.
    • Vagal denervation → Reduced heart rate variability (HRV).
    • Unopposed sympathetic tone → Fixed tachycardia.
    		 Persistent resting tachycardia, orthostatic palpitations.
    • Glycemic control (HbA1c <7%).
    • Fludrocortisone for orthostatic hypotension.
    • Pacing (if severe bradycardia-tachycardia syndrome).
    Brainstem Lesions (e.g., Wallenberg Syndrome)
    • Lateral medullary infarction → Disruption of nucleus tractus solitarius (NTS) and RVLM.
    • Loss of baroreflex integration → Blood pressure lability.
    • Dysautonomia → Paroxysmal hypertension/tachycardia.
    		 Sudden palpitations with hypertension or bradycardia episodes.
    • Antihypertensives (e.g., clonidine, beta-blockers).
    • Rehabilitation for autonomic recovery.
    • Pacemaker if conduction abnormalities develop.

    Post-Traumatic Stress Disorder (PTSD) and Noradrenaline-Mediated Palpitations

    PTSD and flashbacks physically manifest as palpitations through hyperactive noradrenergic pathways, a hallmark of the fight-or-flight response. Trauma exposure leads to amygdala hypertrophy and hypofunction of the prefrontal cortex, resulting in dysregulated stress responses. During flashbacks, the locus coeruleus releases excessive noradrenaline, binding to beta-1 adrenergic receptors in the sinoatrial (SA) node, which increases automaticity and triggers palpitations.

    Key mechanisms include:

  • Enhanced cardiac sympathetic drive: Noradrenaline surges elevate heart rate and contractility.
  • Reduced heart rate variability (HRV): PTSD patients exhibit lower HRV, indicating autonomic imbalance.
  • Increased QT dispersion: Chronic stress may prolong ventricular repolarization, raising arrhythmic risk.

    • Clinical examples include veterans or assault survivors reporting palpitations during re-experiencing symptoms, often accompanied by diaphoresis and hyperventilation. Management strategies focus on:

  • Selective serotonin-norepinephrine reuptake inhibitors (SNRIs) (e.g., venlafaxine) to modulate noradrenaline.
  • Prazosin (alpha-1 blocker) to reduce nightmares and sympathetic overactivity.
  • Mindfulness-based stress reduction (MBSR) to improve autonomic flexibility.

    • Depression and Palpitations: SSRIs, QT Interval, and Autonomic Dysfunction

    Depression is associated with palpitations through autonomic dysfunction, medication side effects, and inflammatory pathways. Serotonin-selective reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are primary antidepressants, but they can alter cardiac physiology in several ways:
    1. QT Interval Prolongation: SSRIs (e.g., citalopram, escitalopram) may prolong the QT interval via

    Heart palpitations serve as a biological alarm, signaling disruptions that range from transient lifestyle influences to life-threatening arrhythmias. The interplay of adrenaline-driven stress responses, electrolyte imbalances, and structural heart disease underscores the necessity of a tailored diagnostic approach—one that integrates patient history, physiological monitoring, and specialized testing. While lifestyle modifications, such as hydration, stress management, and moderation of stimulants, can mitigate benign triggers, persistent or severe palpitations warrant prompt evaluation to rule out conditions like atrial fibrillation or long QT syndrome. Advances in cardiac imaging and genetic testing continue to refine our understanding, emphasizing early intervention as the cornerstone of preventing complications. Ultimately, recognizing the diverse etiologies of palpitations empowers individuals to make informed decisions about their cardiovascular health, bridging the gap between symptom awareness and proactive care.

    FAQ

    Why do I experience heart palpitations specifically at night?

    Nighttime palpitations are often caused by stress or anxiety before sleep, low blood pressure when lying down, or sleep position changes (like lying on your left side). Acid reflux or caffeine/alcohol consumed earlier in the day can also trigger them. In some cases, they may signal an underlying issue like sleep apnea or an irregular heartbeat that needs evaluation.

    What could be causing heart palpitations combined with dizziness?

    Palpitations and dizziness together usually indicate a drop in blood pressure (like from dehydration, standing too quickly, or low blood sugar) or an arrhythmia (e.g., atrial fibrillation). Anxiety or panic attacks can also cause both symptoms. Seek medical attention if these occur frequently or with chest pain, fainting, or shortness of breath.

    What might trigger heart palpitations after eating a meal?

    Eating large, heavy, or fatty meals can cause palpitations due to blood rushing to the digestive system, temporarily straining your heart. Caffeine, alcohol, or spicy foods may also provoke them. For some people, gastroesophageal reflux (GERD) or food sensitivities trigger palpitations. Rarely, it could signal a heart condition like mitral valve prolapse.

    How does perimenopause cause heart palpitations?

    Hormonal fluctuations during perimenopause can disrupt the heart’s electrical system, leading to palpitations. Hot flashes, which cause rapid blood pressure changes, may also trigger them. Stress and sleep disturbances common in this phase can exacerbate symptoms. Most palpitations are harmless, but persistent or severe cases should be checked.

    What are the most common causes of heart palpitations in women?

    Women often experience palpitations due to hormonal changes (menstrual cycle, pregnancy, menopause), anxiety, or thyroid issues (hyperthyroidism). Stress, caffeine, or electrolyte imbalances (like low magnesium) are also frequent triggers. Structural heart problems or arrhythmias can cause them, so unexplained or frequent palpitations warrant medical review.

    Why do some women get heart palpitations during pregnancy?

    Pregnancy-related palpitations are usually caused by increased blood volume, hormonal shifts (like high progesterone), or anemia (low iron). Anxiety or dehydration can also play a role. While often harmless, severe or frequent palpitations should be discussed with a doctor to rule out conditions like arrhythmias or preeclampsia.